Necon 0.5/35
Product Images NDC 42254-287

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Necon 0.5/35 (NDC 42254-287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Norethindrone Chemical Structure (7a62dd77 Bc33 4f4e 9cbf 980e3ec80ff7 01)

FDA Label Image

Ethinyl Estradiol Chemical Structure (7a62dd77 Bc33 4f4e 9cbf 980e3ec80ff7 02)

FDA Label Image

Mestranol Chemical Structure (7a62dd77 Bc33 4f4e 9cbf 980e3ec80ff7 03)

FDA Label Image

Table 2 Chart (7a62dd77 Bc33 4f4e 9cbf 980e3ec80ff7 04)

FDA Label Image

Necon 0.5mg/35mcg (7a62dd77 Bc33 4f4e 9cbf 980e3ec80ff7 05)

Necon 0.5mg/35mcg (7a62dd77 Bc33 4f4e 9cbf 980e3ec80ff7 05)
This is a description of a medication called "Necon 0.5mg/ 35mcg" manufactured and distributed by Watson Pharma, Inc. It comes in the form of tablets that are taken daily over a 28-day period. It contains Norethindrone and Ethinyl Estradiol and is meant for hormonal regulation in women. This communication also provides some information on the dosage, storage instructions, and safety precautions related to the medication. The Product ID is SN028728.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.